To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
StemLifeLine Introduces First Service Allowing IVF Patients to Develop Personal Stem Cell Lines
StemLifeLine has announced that it received approval from the California Department of Health Services (CDHS) to engage in the operation of a tissue bank in accordance with Division 2, Chapter 4.1 of the Health and Safety Code.
With this Tissue Bank license, individuals who have undergone in vitro fertilization (IVF) may now use StemLifeLine's service to develop personal stem cell lines from their remaining stored embryos. StemLifeLine is the first life sciences company to offer this service through IVF centers.
"Developing a personal stem cell line is like buying insurance for the future," stated Ana Krtolica, Ph.D., cofounder, CEO and chief scientific officer (CSO) of StemLifeLine.
"Until now, there have been only three options for frozen embryos remaining from the in vitro fertilization process. They could be donated to research, given up for 'adoption' to other couples or discarded. With our approved California Tissue Bank license, we can now offer IVF patients the option to derive and preserve their own stem cell line for their future use," Krtolica added.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
